Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB.

N Engl J Med. 2000 Dec 28;343(26):1925-32.

2.

Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients.

Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ.

Infect Control Hosp Epidemiol. 2003 Sep;24(9):644-9.

PMID:
14510245
3.

Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.

Ray AJ, Pultz NJ, Bhalla A, Aron DC, Donskey CJ.

Clin Infect Dis. 2003 Oct 1;37(7):875-81. Epub 2003 Sep 12.

PMID:
13130397
4.

Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.

Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y.

Infect Control Hosp Epidemiol. 2008 Aug;29(8):709-15. doi: 10.1086/589582.

PMID:
18631116
5.

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD.

Am J Infect Control. 1995 Jun;23(3):170-80.

PMID:
7677262
6.

Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy.

Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT.

Infect Control Hosp Epidemiol. 2002 Aug;23(8):436-40.

PMID:
12186208
7.
8.

Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital.

Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR, Sexton DJ.

Infect Control Hosp Epidemiol. 1996 Jan;17(1):36-41.

PMID:
8789685
9.

Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens.

Peltroche-Llacsahuanga H, Top J, Weber-Heynemann J, Lütticken R, Haase G.

J Clin Microbiol. 2009 Dec;47(12):4113-6. doi: 10.1128/JCM.00882-09. Epub 2009 Oct 7.

10.

Prospective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit.

Toledano H, Schlesinger Y, Raveh D, Rudensky B, Attias D, Eidelman AI, Yinnon AM.

Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):282-7.

PMID:
10834817
11.

Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.

Schuster F, Graubner UB, Schmid I, Weiss M, Belohradsky BH.

Klin Padiatr. 1998 Jul-Aug;210(4):261-3.

PMID:
9743963
12.

Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece.

Metallidis S, Chatzidimitriou M, Tsona A, Bisiklis A, Lazaraki G, Koumentaki E, Gikas A, Alexiou-Daniel S, Nikolaidis P.

Braz J Infect Dis. 2006 Jun;10(3):179-84.

13.
14.

Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.

Deshpande A, Hurless K, Cadnum JL, Chesnel L, Gao L, Chan L, Kundrapu S, Polinkovsky A, Donskey CJ.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3988-93. doi: 10.1128/AAC.02590-15. Print 2016 Jul.

15.

Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

Gambarotto K, Ploy MC, Turlure P, Grélaud C, Martin C, Bordessoule D, Denis F.

J Clin Microbiol. 2000 Feb;38(2):620-4.

16.

Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns.

Hufnagel M, Liese C, Loescher C, Kunze M, Proempeler H, Berner R, Krueger M.

BMC Infect Dis. 2007 Sep 16;7:107.

17.

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.

Slaughter S, Hayden MK, Nathan C, Hu TC, Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein RA.

Ann Intern Med. 1996 Sep 15;125(6):448-56.

PMID:
8779456
18.

Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.

Stiefel U, Pultz NJ, Helfand MS, Donskey CJ.

Antimicrob Agents Chemother. 2004 Jun;48(6):2144-8.

19.

Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice.

Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA.

Lett Appl Microbiol. 2001 Jul;33(1):84-8.

20.

Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.

Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJ.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S121-6. doi: 10.1093/cid/cis440.

Supplemental Content

Support Center